Push Admin

EU watchdog set to approve first omicron jabs

Article (news)

Danny Kemp, Agence France-Presse

<div class="embed-wrap"><figure data-feedback="fb:likes,fb:comments"><img alt=" A health worker prepares Pfizer’s COVID-19 vaccine inside a mall in Makati City a day after the Department of Health issued guidelines for its nationwide rollout on July 28, 2022. George Calvelo, ABS-CBN News/File" src="https://sa.kapamilya.com/absnews/abscbnnews/media/2022/tvpatrol/08/15/20220728-covid-vaccine-makati-gc-9.jpg"/><figcaption>A health worker prepares Pfizer’s COVID-19 vaccine inside a mall in Makati City a day after the Department of Health issued guidelines for its nationwide rollout on July 28, 2022. <em>George Calvelo, ABS-CBN News/File</em></figcaption></figure></div><p>THE HAGUE — The EU&#x27;s drug regulator is on Thursday expected to authorize the first COVID-19 vaccines for the omicron variant, although they do not target the latest strains.</p><p>The adapted vaccines made by Pfizer/BioNTech and Moderna will be discussed during an extraordinary meeting of the European Medicines Agency.</p><p>European nations have been keen to rush through the new generation of jabs so they can start booster campaigns ahead of a feared COVID surge this winter.</p><p>The 2 so-called &quot;bivalent&quot; vaccines protect against the earlier BA.1 strain of omicron, as well as the original COVID virus that emerged in China in 2019.</p><p>They do not however target the newer and more infectious BA.4 and BA.5 types, which have emerged in recent months as the dominant strains worldwide.</p><ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/overseas/09/01/22/in-the-us-updated-booster-shots-target-covid-omicron-variant">US authorities approve updated booster shots targeting omicron</a></li></ul><p>&quot;The aim of the meeting is to conclude the evaluation of the two applications, if possible,&quot; the Amsterdam-based EMA said.</p><p>&quot;We will communicate on the outcomes of the meeting on 1 September.&quot;</p><p>The agency has said it hopes to approve a separate Pfizer vaccine adapted for the BA.4 and BA.5 types &quot;in the fall&quot;.</p><p>The United States authorized its first anti-omicron vaccines on Wednesday, approving Pfizer and Moderna jabs that were adapted to tackle BA.4 and BA.5.</p><p>Britain authorized the Moderna vaccine for the BA.1 type in mid-August.</p><div><strong>NEW WAVE</strong></div><p>The 27-nation EU is currently still using the same coronavirus vaccines that were approved nearly 2 years ago for use against the original strain.</p><p>While they offer some protection against newer variants, the race has been on to produce jabs that also target the milder but more infectious omicron strains.</p><p>While previous &quot;variants of concern&quot; like Alpha and Delta eventually petered out, omicron and its sublineages have dominated throughout 2022.</p><p>The BA.4 and BA.5 types have in particular helped to drive a wave of new cases of the disease in Europe and the United States in recent months.</p><ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/overseas/08/16/22/uk-clears-new-moderna-vaccine-targeting-omicron-variant">UK clears new Moderna vaccine targeting Omicron variant</a></li>	<li><a href="https://news.abs-cbn.com/overseas/multimedia/photo/08/17/22/british-citizens-get-omicron-booster-jab">British citizens get Omicron booster jab</a></li></ul><p>Health authorities have therefore been keen to get updated vaccines as soon as possible ahead of a feared new wave of the disease later this year.</p><p>All omicron variants tend to have a milder disease course as they settle less in the lungs and more in the upper nasal passages, causing symptoms like fever, tiredness and loss of smell.</p><p>The EMA said its review of the adapted Pfizer and Moderna vaccines focused on data from laboratory studies and from tests on the immune response against the original strain and the omicron variant.</p><p>The adapted vaccines under consideration Thursday &quot;more closely match the original strain and the BA.1 Omicron subvariant,&quot; the agency said.</p><div><strong>RELATED VIDEO</strong></div><figure class="op-interactive"><iframe allow="autoplay; fullscreen" frameBorder="0" height="100%" id="ivsplayer01" scrolling="no" src="https://player.ivideosmart.com/ivsplayer/v4/dist/html/iframe-src.html?iframeid=ivsplayer01&amp;key=e8c22c015ca9eafa76f1e3edfa03c603&amp;spid=3001339&amp;vid=2205620" width="100%"></iframe></figure><div class="iwantbar">Watch more News on <a href="https://www.iwanttfc.com/#!/browse/Genres/News/tag_id_genres/id_news" target="_blank">iWantTFC</a></div><div> </div>

The EU's drug regulator is expected to authorize the first COVID-19 vaccines for the omicron variant, although they do not target the latest strains.

EU watchdog set to approve first omicron jabs

News

Entertainment

Lifestyle

Sports

Metro.Style

More

Traffic

Manila

Horoscope

Overseas

EU watchdog set to approve first omicron jabs

Danny Kemp,

Agence France-Presse

Published Sep 01, 2022 04:02 PM PHT

Read More:

European Union

COVID-19

COVID19

coronavirus

COVID-19 vaccine

COVID-19 booster

omicron

Pfizer

Moderna

bivalent vaccine

ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.

Corporate

Investors

Governance

International Distribution

Corporate

Governance

Investors

International Distribution

NPC Seal of Registration

Privacy Policy

AI Policy

Terms of Service

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.